Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1216

1.

An analysis of rotavirus vaccine reports to the vaccine adverse event reporting system: more than intussusception alone?

Haber P, Chen RT, Zanardi LR, Mootrey GT, English R, Braun MM; VAERS Working Group.

Pediatrics. 2004 Apr;113(4):e353-9.

PMID:
15060267
2.

Rotavirus vaccines and vaccination in Latin America.

Linhares AC, Bresee JS.

Rev Panam Salud Publica. 2000 Nov;8(5):305-31. Review.

PMID:
11190969
3.

Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.

Zhou W, Pool V, Iskander JK, English-Bullard R, Ball R, Wise RP, Haber P, Pless RP, Mootrey G, Ellenberg SS, Braun MM, Chen RT.

MMWR Surveill Summ. 2003 Jan 24;52(1):1-24. Erratum in: MMWR Morb Mortal Wkly Rep. 2003 Feb 14;52(06):113.

4.

Suspension of rotavirus vaccine after reports of intussusception--United States, 1999.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2004 Sep 3;53(34):786-9. Erratum in: MMWR Morb Mortal Wkly Rep. 2004 Sep 24;53(37):879.

5.

The first oral rotavirus vaccine, 1998-1999: estimates of uptake from the National Immunization Survey.

Smith PJ, Schwartz B, Mokdad A, Bloch AB, McCauley M, Murphy TV.

Public Health Rep. 2003 Mar-Apr;118(2):134-43.

6.

Rotavirus live, oral, pentavalent vaccine.

Tom-Revzon C.

Clin Ther. 2007 Dec;29(12):2724-37. doi: 10.1016/j.clinthera.2007.12.018. Review.

PMID:
18201590
8.

Intussusception among recipients of rotavirus vaccine--United States, 1998-1999.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 1999 Jul 16;48(27):577-81.

9.

Symptoms associated with rhesus-human reassortant rotavirus vaccine in infants.

Joensuu J, Koskenniemi E, Vesikari T.

Pediatr Infect Dis J. 1998 Apr;17(4):334-40.

PMID:
9576390
10.

Safety, efficacy, and immunogenicity of 2 doses of bovine-human (UK) and rhesus-rhesus-human rotavirus reassortant tetravalent vaccines in Finnish children.

Vesikari T, Karvonen AV, Majuri J, Zeng SQ, Pang XL, Kohberger R, Forrest BD, Hoshino Y, Chanock RM, Kapikian AZ.

J Infect Dis. 2006 Aug 1;194(3):370-6. Epub 2006 Jun 23.

11.

Intussusception among recipients of rotavirus vaccine: reports to the vaccine adverse event reporting system.

Zanardi LR, Haber P, Mootrey GT, Niu MT, Wharton M.

Pediatrics. 2001 Jun;107(6):E97.

PMID:
11389295
13.

Intussusception among infants given an oral rotavirus vaccine.

Murphy TV, Gargiullo PM, Massoudi MS, Nelson DB, Jumaan AO, Okoro CA, Zanardi LR, Setia S, Fair E, LeBaron CW, Wharton M, Livengood JR; Rotavirus Intussusception Investigation Team.

N Engl J Med. 2001 Feb 22;344(8):564-72. Erratum in: N Engl J Med 2001 May 17;344(20):1564. Livingood, JR [corrected to Livengood, JR].

14.

Enhancing vaccine safety surveillance: a capture-recapture analysis of intussusception after rotavirus vaccination.

Verstraeten T, Baughman AL, Cadwell B, Zanardi L, Haber P, Chen RT; Vaccine Adverse Event Reporting System Team.

Am J Epidemiol. 2001 Dec 1;154(11):1006-12.

15.

Postmarketing monitoring of intussusception after RotaTeq vaccination--United States, February 1, 2006-February 15, 2007.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2007 Mar 16;56(10):218-22.

17.
18.

Population-based study of rotavirus vaccination and intussusception.

Kramarz P, France EK, Destefano F, Black SB, Shinefield H, Ward JI, Chang EJ, Chen RT, Shatin D, Hill J, Lieu T, Ogren JM.

Pediatr Infect Dis J. 2001 Apr;20(4):410-6.

PMID:
11332666
19.

Neonatal administration of rhesus rotavirus tetravalent vaccine.

Vesikari T, Karvonen A, Forrest BD, Hoshino Y, Chanock RM, Kapikian AZ.

Pediatr Infect Dis J. 2006 Feb;25(2):118-22.

PMID:
16462287
20.
Items per page

Supplemental Content

Write to the Help Desk